Treatment of High-Risk Older Persons With Lipid-Lowering Drug Therapy-Reference-Cited by-同舟云学术

Treatment of High-Risk Older Persons With Lipid-Lowering Drug Therapy

Published:2008-03 Issue:2 Volume:15 Page:102-107
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:

Author:

Aronow Wilbert S

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference34 articles.

1. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.;Lancet,2002

2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S).;Lancet,1994

3. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S).;Miettinen;Circulation,1997

4. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S).;Pedersen;Am J Cardiol,1998

5. Follow-up study of patients randomized in the Scandinavian Simvastatin Survival Study (4S) of cholesterol lowering.;Pedersen;Am J Cardiol,2000

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical discrepancies and their potential impact on biomarkers and precision medicine initiative;Biomarkers, Diagnostics and Precision Medicine in the Drug Industry;2019

2. Hypolipidemic and cardioprotective effects of Ulva lactuca ethanolic extract in hypercholesterolemic mice;Archives of Physiology and Biochemistry;2017-11-24

3. Biomarkers of Subclinical Atherosclerosis and Natural Products as Complementary Alternative Medicine;Current Pharmaceutical Design;2015-12-21

4. Effects of Campomanesia xanthocarpa on inflammatory processes, oxidative stress, endothelial dysfunction and lipid biomarkers in hypercholesterolemic individuals;Atherosclerosis;2014-05

5. Effect of Cardiovascular Drugs on Cardiovascular Events in 1599 Patients Followed in an Academic Outpatient Cardiology Practice;American Journal of Therapeutics;2014-03